Parameter
| Biomarker | Osteopontin | Full name | Osteopontin | Molecular Type | Protein（Cytokines / Angiogenic factors） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis, Prediction of treatment response |
| Disease | Renal Cell Carcinoma(RCC) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Serum（ELISA） | ||
| Pathobiological Mechanisms | Participate in tumor invasion, angiogenesis and regulation of tumor microenvironment | ||||
| Clinical Availability Status | Study test: Prognostic biomarkers for sorafenib combined with interferon therapy | ||||
| Notes and Dynamics | Patients with low baseline levels had shorter progression-free survival (PFS) with sorafenib monotherapy and required combination therapy | ||||